Monopar Therapeutics
Company Stats
- Market Cap
- $534.8M
- as of Sep 30, 2026
- Shares Outstanding
- 6.7M
- Free Float
- 78.0%
Income Statement
- Revenue
- $0
- Operating Income
- -$16.7M
- Net Income
- -$13.7M
Balance Sheet
- Cash & Equivalents
- $61.8M
Returns & Capital
- Share Repurchases
- $35.0M
- SBC, 3Y Avg
- $2.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $0 | — | — |
| FY2024 | $0 | — | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 18, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Companies Report Firm Demand, Relentless Cost Pressure